Lexaria Bioscience Announces Australian Tax Office Pays AU$3.667M In Tax Rebate To Co.
Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that it has received a cash rebate of AUD$3,666,611.98 from
Lexaria got back about $3.7 million in taxes from Australia because of money they spent on research there. This is like a refund that gives the company extra cash to spend, which is helpful when a company is still growing and building things.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.